All Topics


The Share of Ozempic Users with Diabetes has Decreased Over Time, Indicating Increased Off-label Use

Ozempic, a relatively new anti-diabetes drug, has been in the headlines because of widespread shortages that are making it difficult for patients who use the drug to manage diabetes to access it. Some news articles suggest that off-label use for weight loss has been a factor associated with increased demand. The active ingredient in Ozempic is semaglutide, which helps regulate insulin product...

Continue reading